186 related articles for article (PubMed ID: 16291214)
21. Challenges and new technologies in adoptive cell therapy.
Zhang P; Zhang G; Wan X
J Hematol Oncol; 2023 Aug; 16(1):97. PubMed ID: 37596653
[TBL] [Abstract][Full Text] [Related]
22. Gene-Based Natural Killer Cell Therapies for the Treatment of Pediatric Hematologic Malignancies.
Rahnama R; Christodoulou I; Bonifant CL
Hematol Oncol Clin North Am; 2022 Aug; 36(4):745-768. PubMed ID: 35773048
[TBL] [Abstract][Full Text] [Related]
23. Identification and Optimization of a Novel HIV-1 Integrase Inhibitor.
Adu-Ampratwum D; Pan Y; Koneru PC; Antwi J; Hoyte AC; Kessl J; Griffin PR; Kvaratskhelia M; Fuchs JR; Larue RC
ACS Omega; 2022 Feb; 7(5):4482-4491. PubMed ID: 35155940
[TBL] [Abstract][Full Text] [Related]
24. High-level resistance to bictegravir and cabotegravir in subtype A- and D-infected HIV-1 patients failing raltegravir with multiple resistance mutations.
Ndashimye E; Li Y; Reyes PS; Avino M; Olabode AS; Kityo CM; Kyeyune F; Nankya I; Quiñones-Mateu ME; Barr SD; Arts EJ
J Antimicrob Chemother; 2021 Oct; 76(11):2965-2974. PubMed ID: 34453542
[TBL] [Abstract][Full Text] [Related]
25. HIV-1 integration sites in CD4+ T cells during primary, chronic, and late presentation of HIV-1 infection.
Kok YL; Vongrad V; Chaudron SE; Shilaih M; Leemann C; Neumann K; Kusejko K; Di Giallonardo F; Kuster H; Braun DL; Kouyos RD; Günthard HF; Metzner KJ
JCI Insight; 2021 May; 6(9):. PubMed ID: 33784259
[TBL] [Abstract][Full Text] [Related]
26. Quantifying the clonality and dynamics of the within-host HIV-1 latent reservoir.
Ferreira RC; Prodger JL; Redd AD; Poon AFY
Virus Evol; 2021 Jan; 7(1):veaa104. PubMed ID: 33505711
[TBL] [Abstract][Full Text] [Related]
27. Influence of the amino-terminal sequence on the structure and function of HIV integrase.
Eilers G; Gupta K; Allen A; Zhou J; Hwang Y; Cory MB; Bushman FD; Van Duyne G
Retrovirology; 2020 Aug; 17(1):28. PubMed ID: 32867805
[TBL] [Abstract][Full Text] [Related]
28. Applications of molecular engineering in T-cell-based immunotherapies.
McBride DA; Kerr MD; Wai SL; Shah NJ
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Sep; 11(5):e1557. PubMed ID: 30972976
[TBL] [Abstract][Full Text] [Related]
29. Post-mitotic BET-induced reshaping of integrase quaternary structure supports wild-type MLV integration.
Borrenberghs D; Zurnic I; De Wit F; Acke A; Dirix L; Cereseto A; Debyser Z; Hendrix J
Nucleic Acids Res; 2019 Feb; 47(3):1195-1210. PubMed ID: 30445610
[TBL] [Abstract][Full Text] [Related]
30. Can Bovine Leukemia Virus Be Related to Human Breast Cancer? A Review of the Evidence.
Martinez Cuesta L; Lendez PA; Nieto Farias MV; Dolcini GL; Ceriani MC
J Mammary Gland Biol Neoplasia; 2018 Sep; 23(3):101-107. PubMed ID: 29777406
[TBL] [Abstract][Full Text] [Related]
31. CAR-T cell therapy in ovarian cancer: from the bench to the bedside.
Zhu X; Cai H; Zhao L; Ning L; Lang J
Oncotarget; 2017 Sep; 8(38):64607-64621. PubMed ID: 28969098
[TBL] [Abstract][Full Text] [Related]
32. The impact of p53 on the early stage replication of retrovirus.
Kinnetz M; Alghamdi F; Racz M; Hu W; Shi B
Virol J; 2017 Aug; 14(1):151. PubMed ID: 28793904
[TBL] [Abstract][Full Text] [Related]
33. Genetic Modification of T Cells.
Morgan RA; Boyerinas B
Biomedicines; 2016 Apr; 4(2):. PubMed ID: 28536376
[TBL] [Abstract][Full Text] [Related]
34. Domestic chickens activate a piRNA defense against avian leukosis virus.
Sun YH; Xie LH; Zhuo X; Chen Q; Ghoneim D; Zhang B; Jagne J; Yang C; Li XZ
Elife; 2017 Apr; 6():. PubMed ID: 28384097
[TBL] [Abstract][Full Text] [Related]
35. Measurement of In Vitro Integration Activity of HIV-1 Preintegration Complexes.
Balasubramaniam M; Davids B; Addai AB; Pandhare J; Dash C
J Vis Exp; 2017 Feb; (120):. PubMed ID: 28287538
[TBL] [Abstract][Full Text] [Related]
36. HIV-1 Integrates Widely throughout the Genome of the Human Blood Fluke Schistosoma mansoni.
Suttiprapa S; Rinaldi G; Tsai IJ; Mann VH; Dubrovsky L; Yan HB; Holroyd N; Huckvale T; Durrant C; Protasio AV; Pushkarsky T; Iordanskiy S; Berriman M; Bukrinsky MI; Brindley PJ
PLoS Pathog; 2016 Oct; 12(10):e1005931. PubMed ID: 27764257
[TBL] [Abstract][Full Text] [Related]
37. Host Factors in Retroviral Integration and the Selection of Integration Target Sites.
Craigie R; Bushman FD
Microbiol Spectr; 2014 Dec; 2(6):. PubMed ID: 26104434
[TBL] [Abstract][Full Text] [Related]
38. Transposable Phage Mu.
Harshey RM
Microbiol Spectr; 2014 Oct; 2(5):. PubMed ID: 26104374
[TBL] [Abstract][Full Text] [Related]
39. High-throughput monitoring of integration site clonality in preclinical and clinical gene therapy studies.
Giordano FA; Appelt JU; Link B; Gerdes S; Lehrer C; Scholz S; Paruzynski A; Roeder I; Wenz F; Glimm H; von Kalle C; Grez M; Schmidt M; Laufs S
Mol Ther Methods Clin Dev; 2015; 2():14061. PubMed ID: 26052530
[TBL] [Abstract][Full Text] [Related]
40. Integrase inhibitor reversal dynamics indicate unintegrated HIV-1 dna initiate de novo integration.
Thierry S; Munir S; Thierry E; Subra F; Leh H; Zamborlini A; Saenz D; Levy DN; Lesbats P; Saïb A; Parissi V; Poeschla E; Deprez E; Delelis O
Retrovirology; 2015 Mar; 12():24. PubMed ID: 25808736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
